One vitamin d pill before surgery may cut infection risk
NCT ID NCT07006714
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether giving a single high-dose vitamin D pill to patients with low vitamin D levels before hip or knee replacement surgery can reduce complications like infection. About 200 adults with osteoarthritis and vitamin D deficiency will receive 300,000 IU of vitamin D3 before surgery. Researchers will track infections, hospital stay length, and readmission rates.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Vitamin D3
- What this could lead to
- If it works, this could show that correcting vitamin D deficiency before joint replacement surgery lowers the risk of infection and other complications.
- What could go wrong
- This is a small, single-center study with only 200 participants. The high dose may cause side effects, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 96 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Serum 25(OH)D \< 30 ng/mL within 2 weeks of surgery. * Able to provide informed consent. Exclusion Criteria: * Follow-up duration \< 90 days anticipated. * Acute hepatitis, cancer, organ transplant recipients, or dialysis patients. * Extra vitamin D supplementation within 90 days post-surgery. * Preoperative serum 25(OH)D ≥ 30 ng/mL. * Adults unable to consent (excluded). * Individuals under 18 (excluded). * Pregnant women (excluded). * Prisoners (excluded).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteoarthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
Miami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Surgeons test augmented reality to Fine-Tune knee replacement cuts
- Can a purified form of ibuprofen better tame osteoarthritis pain?
- Could simple home exercises be the key to better knee health?
- Can a new plastic hip liner outlast the old ones?
- Which injection eases arm pain better: steroid or Anti-Inflammatory?